Hypnite
Indicated to address sleep latency and maintenance by modulating neurotransmitter activity in the central nervous system.
Strengths: 1 · 2 · 3mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Lunesta
- Therapeutic class
Cyclopyrrolone Hypnotic
- Pharmacological class
Nonbenzodiazepine Hypnotic
- Contraindications
hypersensitivity to eszopiclone; myasthenia gravis
- Minor side effects
unpleasant taste; headache; somnolence; dizziness
- Moderate side effects
diarrhoea; nausea; xerostomia; peripheral oedema
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Hab Pharma
- Onset Time
30–60 minutes
- Duration
6–8 hours
- Storage instructions
Store in a cool, dry place away from moisture.
- Drug interactions
alcohol; benzodiazepines; opioids; anticonvulsants
- Age restrictions
Adults only.
Serious side effects
anaphylaxis — requires immediate medical attention; hallucinations — requires immediate medical attention
Patient summary
Indicated to address sleep latency and maintenance by modulating neurotransmitter activity in the central nervous system.
Mechanism of action
Eszopiclone interacts with the GABA-A receptor complex, enhancing neuronal inhibition and effectively reducing the time required to fall asleep while helping to maintain sleep continuity.
Pregnancy and breastfeeding
Pregnancy: Use only if potential benefit outweighs risk. Breastfeeding: Not recommended.
Hypnite
Indicated to address sleep latency and maintenance by modulating neurotransmitter activity in the central nervous system.
Editorial Notes
- Active ingredient(s): Eszopiclone
- Listed indication(s): Insomnia